Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Myelogenous Leukemia AML”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03678493
What this trial is testing

FMT in Patients With AML Allo HSCT in Recipients

Who this might be right for
Acute Myeloid LeukemiaAllogeneic Hematopoietic Cell Transplantation
Masonic Cancer Center, University of Minnesota 100
Testing effectiveness (Phase 2)UnknownNCT04632316
What this trial is testing

A Trial to Evaluate the Safety and Efficacy of oNKord® in Subjects With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Glycostem Therapeutics BV 33
Early research (Phase 1)Active Not RecruitingNCT04227847
What this trial is testing

A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid Leukemia
Seagen, a wholly owned subsidiary of Pfizer 170
Not applicableEnded earlyNCT01962636
What this trial is testing

Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

Who this might be right for
Acute Myeloid Leukemia (AML)Acute Lymphocytic Leukemia (ALL)Chronic Myelogenous Leukemia+15 more
Masonic Cancer Center, University of Minnesota 200
Testing effectiveness (Phase 2)Study completedNCT00968071
What this trial is testing

Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndrome

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
M.D. Anderson Cancer Center 71
Early research (Phase 1)Study completedNCT00003693
What this trial is testing

Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndromes
M.D. Anderson Cancer Center 30
Post-approval studies (Phase 4)Study completedNCT00487448
What this trial is testing

SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia

Who this might be right for
Myelodysplastic SyndromeAcute Myeloblastic Leukemia
PETHEMA Foundation 200
Early research (Phase 1)Study completedNCT03441048
What this trial is testing

Lintuzumab-Ac225 in Combination with Cladribine + Cytarabine + Filgastrim + Mitoxantrone (CLAG-M) for Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Medical College of Wisconsin 26
Testing effectiveness (Phase 2)Ended earlyNCT02259348
What this trial is testing

Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)Myeloid Sarcoma+4 more
St. Jude Children's Research Hospital 12
Not applicableNot Yet RecruitingNCT06714071
What this trial is testing

Relation of C-reactive Protein/ Albumin Ratio and Coagulation Profile in Acute Myeloid Leukemia Patients

Who this might be right for
AML
Assiut University 80
Early research (Phase 1)Ended earlyNCT02231853
What this trial is testing

Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections

Who this might be right for
Chronic Lymphocytic LeukemiaCML (Chronic Myelogenous Leukemia)MDS (Myelodysplastic Syndrome)+2 more
National Heart, Lung, and Blood Institute (NHLBI) 12
Not applicableUnknownNCT03499912
What this trial is testing

Screening of IDH1 and IDH2 Gene Mutations in Adult Acute Myeloid Leukemia for Possible Targeted Therapy

Who this might be right for
Acute Myeloid Leukemia
National Taiwan University Hospital 300
Early research (Phase 1)Study completedNCT02750995
What this trial is testing

Peptide Vaccination in Combination With Azacitidine for Patients With MDS and AML

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid Leukemia
Daniel El Fassi 5
Testing effectiveness (Phase 2)Study completedNCT02756572
What this trial is testing

Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms

Who this might be right for
Blasts 10 Percent or More of Bone Marrow Nucleated CellsChronic Myelomonocytic Leukemia-2High Grade Malignant Neoplasm+6 more
University of Washington 30
Testing effectiveness (Phase 2)Study completedNCT03434730
What this trial is testing

Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaAcute Leukemia+6 more
Memorial Sloan Kettering Cancer Center 46
Testing effectiveness (Phase 2)UnknownNCT04669067
What this trial is testing

TL-895 and KRT-232 Study in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Telios Pharma, Inc. 18
Testing effectiveness (Phase 2)Study completedNCT01866839
What this trial is testing

Preventing Stem Cell Transplant Complications With a Blood Separator Machine

Who this might be right for
MDS (Myelodysplastic Syndrome)Myeloproliferative DisorderLymphoma, Non-Hodgkin+2 more
National Heart, Lung, and Blood Institute (NHLBI) 41
Testing effectiveness (Phase 2)Looking for participantsNCT07451912
What this trial is testing

Venetoclax Plus Hypomethylating Agents and Subcutaneous Cytarabine for CEBPA-Mutated AML

Who this might be right for
Acute Myeloid Leukemia (AML)CEBPA MutationUnfit, New-diagnosis AML
The First Affiliated Hospital of Soochow University 29
Not applicableEnded earlyNCT00290628
What this trial is testing

Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDiamond-blackfan AnemiaFanconi Anemia+6 more
Masonic Cancer Center, University of Minnesota 43
Large-scale testing (Phase 3)Study completedNCT01305200
What this trial is testing

Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant

Who this might be right for
Childhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in RemissionChildhood Chronic Myelogenous Leukemia+24 more
Children's Oncology Group 226
Next Page